Questions and answers: What can be said by diagnostic imaging in neuroendocrine tumors?

V. Cuccurullo; A. Faggiano; M. Scialpi; G. L. Cascini; A. Piunno; O. Catalano; A. Colao; L. Mansi

Questions and answers: What can be said by diagnostic imaging in neuroendocrine tumors?

V. Cuccurullo, A. Faggiano, M. Scialpi, G. L. Cascini, A. Piunno, O. Catalano, A. Colao, L. Mansi

Istituto Nazionale Tumori Fondazione G. Pascale

Research output: Contribution to journal › Article › peer-review

Abstract

The neuroendocrine tumors (NET) of the gastro-entero-pancreatic area (GEP) represent a heterogeneous group of malignancies from the histologic, clinico-laboratoristic (functioning and non-functioning variants), and therapeutic point of view. It is an issue becoming more frequent for the diagnostic imager, being radiologist as well as nuclear physician. Imaging (together with biopsy) plays a key role in the diagnostic assessment and staging (including grading and prognostic definition), in evaluating response to treatment, and in follow-up of GEP-NET. Multislice computed tomography (MSCT), octreoscan and PET-CT are the most widely diffuse and accurate imaging modalities employed in this setting. Other methods, such as Magnetic Resonance and Endoscopic Ultrasound, may also play a significant role.

Original language	English
Pages (from-to)	367-377
Number of pages	11
Journal	Minerva Endocrinologica
Volume	37
Issue number	4
Publication status	Published - Dec 2012

Keywords

Diagnostic imaging
Neuroendocrine tumors
Nuclear medicine
Radiology

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Internal Medicine
Endocrinology

Fingerprint Dive into the research topics of 'Questions and answers: What can be said by diagnostic imaging in neuroendocrine tumors?'. Together they form a unique fingerprint.

Cite this

@article{cd514c1b21f54a3fbbfc79009ba75089,

title = "Questions and answers: What can be said by diagnostic imaging in neuroendocrine tumors?",

abstract = "The neuroendocrine tumors (NET) of the gastro-entero-pancreatic area (GEP) represent a heterogeneous group of malignancies from the histologic, clinico-laboratoristic (functioning and non-functioning variants), and therapeutic point of view. It is an issue becoming more frequent for the diagnostic imager, being radiologist as well as nuclear physician. Imaging (together with biopsy) plays a key role in the diagnostic assessment and staging (including grading and prognostic definition), in evaluating response to treatment, and in follow-up of GEP-NET. Multislice computed tomography (MSCT), octreoscan and PET-CT are the most widely diffuse and accurate imaging modalities employed in this setting. Other methods, such as Magnetic Resonance and Endoscopic Ultrasound, may also play a significant role.",

keywords = "Diagnostic imaging, Neuroendocrine tumors, Nuclear medicine, Radiology",

author = "V. Cuccurullo and A. Faggiano and M. Scialpi and Cascini, {G. L.} and A. Piunno and O. Catalano and A. Colao and L. Mansi",

year = "2012",

month = dec,

language = "English",

volume = "37",

pages = "367--377",

journal = "Minerva Endocrinologica",

issn = "0391-1977",

publisher = "Edizioni Minerva Medica S.p.A.",

number = "4",

}

TY - JOUR

T1 - Questions and answers

T2 - What can be said by diagnostic imaging in neuroendocrine tumors?

AU - Cuccurullo, V.

AU - Faggiano, A.

AU - Scialpi, M.

AU - Cascini, G. L.

AU - Piunno, A.

AU - Catalano, O.

AU - Colao, A.

AU - Mansi, L.

PY - 2012/12

Y1 - 2012/12

N2 - The neuroendocrine tumors (NET) of the gastro-entero-pancreatic area (GEP) represent a heterogeneous group of malignancies from the histologic, clinico-laboratoristic (functioning and non-functioning variants), and therapeutic point of view. It is an issue becoming more frequent for the diagnostic imager, being radiologist as well as nuclear physician. Imaging (together with biopsy) plays a key role in the diagnostic assessment and staging (including grading and prognostic definition), in evaluating response to treatment, and in follow-up of GEP-NET. Multislice computed tomography (MSCT), octreoscan and PET-CT are the most widely diffuse and accurate imaging modalities employed in this setting. Other methods, such as Magnetic Resonance and Endoscopic Ultrasound, may also play a significant role.

AB - The neuroendocrine tumors (NET) of the gastro-entero-pancreatic area (GEP) represent a heterogeneous group of malignancies from the histologic, clinico-laboratoristic (functioning and non-functioning variants), and therapeutic point of view. It is an issue becoming more frequent for the diagnostic imager, being radiologist as well as nuclear physician. Imaging (together with biopsy) plays a key role in the diagnostic assessment and staging (including grading and prognostic definition), in evaluating response to treatment, and in follow-up of GEP-NET. Multislice computed tomography (MSCT), octreoscan and PET-CT are the most widely diffuse and accurate imaging modalities employed in this setting. Other methods, such as Magnetic Resonance and Endoscopic Ultrasound, may also play a significant role.

KW - Diagnostic imaging

KW - Neuroendocrine tumors

KW - Nuclear medicine

KW - Radiology

UR - http://www.scopus.com/inward/record.url?scp=84875353980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875353980&partnerID=8YFLogxK

M3 - Article

C2 - 23235192

AN - SCOPUS:84875353980

VL - 37

SP - 367

EP - 377

JO - Minerva Endocrinologica

JF - Minerva Endocrinologica

SN - 0391-1977

IS - 4

ER -